Email Us : +91 33 24549650

Addressing Breast Cancer with Epirubicin | Anzen Exports

March 12, 2022by Anzen_Exports0

Anthracyclines were first introduced in 1970 to treat metastatic breast cancer. Epirubicin is an analogue of anthracyclines and is effective as the first line of treatment for breast cancer. It is an anti-cancer chemotherapy drug, classified as an “anthracycline antitumor antibiotic.” (1)

Addressing Breast Cancer with Epirubicin


Role in Treating Cancer

As an antitumour antibiotic, Epiburicin is made from natural products by species of the soil fungus, Streptomyces. These drugs act during multiple cell cycle phases and are considered cell-specific. Doxorubicin, Daun orubicin, Mitoxantrone, and Idarubicin are other anthracyline antitumour antibiotics.

Epirubicin is used to treat cancer as that of blood, breast, stomach, lung, ovaries and soft tissues. It also helps to prevent the recurrence of bladder cancer after surgery.

It is used as adjuvant therapy in women who have had surgery and a condition of lymph node involvement. It may also be used in place of doxorubicin in some cases. It may be used solo or with other medicines as combination chemotherapy.

Addressing Breast Cancer with Epirubicin


Cancerous tumours are characterised by cell division and are no longer controllable, as in the case of normal tissue. Normal cells typically exhibit Contact inhibition which means they do not divide when in contact with like cells. This ability is lost in cancer cells, and the cell cycle continues continuously. In chemotherapy administration, the cell division is stopped. The drug works by damaging the RNA or DNA that tells the cell how to copy itself in the division. When the cells are unable to divide, they die. The faster the cells divide; it becomes probable that chemotherapy will kill the cells and thus cause the tumour to shrink and degenerate. It also leads to cell suicide (self-death or apoptosis).

Chemotherapy drugs such as Epirubicin are effective on cells at rest, also called cell-cycle nonspecific. The chemotherapy schedule is planned based on the rate at which the cells divide, the cells and the time when the drug is effective. The significant disadvantage is that this drug does not recognise the difference between cancer cells and normal cells. These normal cells, such as the blood cells, the mouth and stomach cells, bowel cells, hair follicles, also get affected. They also face degenerative side effects caused during chemotherapy.


Epirubicin is administered as an intravenous injection (IV). The syringe needle is directly placed into the tube of a free-flowing IV solution, which goes straight into a central line when the drug is introduced after a few minutes. Being a vesicant, Epirubicin must be administered by a trained medical practitioner only. The drug dosage depends on the patient’s height and weight, general health and the type of cancer or condition being treated.

Side Effects

The severity of the side effects of Epirubicin being administered depends on the drug’s dosage. The common symptoms observed are mouth sores, hair loss on the scalp, nausea and vomiting, fatigue, amenorrhea and low blood count in the later stages of the treatment.

Precautions observed for Epirubicin drug therapy include making the doctor know about any other drugs taken. It is good to avoid Epirubicin therapy if a woman is pregnant or lactating. Avoid any vaccination or immunisation shots if the patient is sensitive to sunlight and people with congestive heart failure.

Breast Cancer treatment can be further enhanced with self-care measures like avoiding crowded places, washing hands often, using a soft toothbrush in case of mouth sores, avoiding contact sports, avoiding sun exposure, drinking 2-3 litres of liquid daily, and maintaining good health nutrition and getting plenty of rest. (2) 

Breast cancer is treatable if diagnosed early. Addressing Breast cancer with drugs such as Epirubicin therapy is effective.

Anzen Exports: Redefining Healthcare

Anzen Exports is well-known for its high-quality Active Pharmaceutical Compounds, herbal extracts, nutraceutical ingredients, and cosmetic ingredients. It is active in the domestic and international trade of Active Pharmaceutical Ingredients. The firm utilised its most significant resources and staff to expand its network with India’s leading manufacturers.

Anzen Exports is a vertically integrated healthcare company. It works toward the same aim of offering the finest services for the Pharmaceutical Industry’s demands.

For more details, visit 


Anzen Export’s blog posts have been written with the information gathered from approved medical journals and websites online. Our research and technical team strive to provide relevant information through such articles. We advise consulting a doctor about an ingredient or medicine before taking it to be best informed.  



Leave a Reply

Your email address will not be published. Required fields are marked *


Anzen Exports

20C Hazra Road, Kolkata 700026, West Bengal,

+91 33 24549650


Follow Our Activity On


Subscribe to our Newsletter